These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 36509063)
1. Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria. Mohammed R; Asres MS; Gudina EK; Adissu W; Johnstone H; Marrast AC; Donini C; Duparc S; Yilma D Am J Trop Med Hyg; 2023 Jan; 108(1):81-84. PubMed ID: 36509063 [TBL] [Abstract][Full Text] [Related]
2. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069 [TBL] [Abstract][Full Text] [Related]
3. Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Sinxadi P; Donini C; Johnstone H; Langdon G; Wiesner L; Allen E; Duparc S; Chalon S; McCarthy JS; Lorch U; Chibale K; Möhrle J; Barnes KI Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932368 [TBL] [Abstract][Full Text] [Related]
4. Spiroindolone KAE609 for falciparum and vivax malaria. White NJ; Pukrittayakamee S; Phyo AP; Rueangweerayut R; Nosten F; Jittamala P; Jeeyapant A; Jain JP; Lefèvre G; Li R; Magnusson B; Diagana TT; Leong FJ N Engl J Med; 2014 Jul; 371(5):403-10. PubMed ID: 25075833 [TBL] [Abstract][Full Text] [Related]
5. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048. McCarthy JS; Donini C; Chalon S; Woodford J; Marquart L; Collins KA; Rozenberg FD; Fidock DA; Cherkaoui-Rbati MH; Gobeau N; Möhrle JJ Clin Infect Dis; 2020 Dec; 71(10):e657-e664. PubMed ID: 32239164 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960 [TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia. Mohammed H; Sime H; Hailgiorgis H; Gubae K; Haile M; Solomon H; Etana K; Girma S; Bekele W; Chernet M; Tollera G; Tasew G; Gidey B; Commons RJ; Assefa A Malar J; 2022 Nov; 21(1):351. PubMed ID: 36437454 [TBL] [Abstract][Full Text] [Related]
9. Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria. White NJ; Duong TT; Uthaisin C; Nosten F; Phyo AP; Hanboonkunupakarn B; Pukrittayakamee S; Jittamala P; Chuthasmit K; Cheung MS; Feng Y; Li R; Magnusson B; Sultan M; Wieser D; Xun X; Zhao R; Diagana TT; Pertel P; Leong FJ N Engl J Med; 2016 Sep; 375(12):1152-60. PubMed ID: 27653565 [TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria. Karl S; Laman M; Moore BR; Benjamin JM; Salib M; Lorry L; Maripal S; Siba P; Robinson LJ; Mueller I; Davis TM Acta Trop; 2016 Aug; 160():1-8. PubMed ID: 27056132 [TBL] [Abstract][Full Text] [Related]
12. Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA). Thriemer K; Degaga TS; Christian M; Alam MS; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Karahalios A; Rajasekhar M; Simpson JA; Rumaseb A; Mnjala H; Lee G; Anose RT; Kidane FG; Woyessa A; Baird K; Sutanto I; Hailu A; Price RN Trials; 2022 May; 23(1):416. PubMed ID: 35585641 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Duparc S; Borghini-Fuhrer I; Craft CJ; Arbe-Barnes S; Miller RM; Shin CS; Fleckenstein L Malar J; 2013 Feb; 12():70. PubMed ID: 23433102 [TBL] [Abstract][Full Text] [Related]
14. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Benjamin J; Moore B; Lee ST; Senn M; Griffin S; Lautu D; Salman S; Siba P; Mueller I; Davis TM Antimicrob Agents Chemother; 2012 May; 56(5):2465-71. PubMed ID: 22330921 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia. Asih PBS; Rozi IE; Dewayanti FK; Wangsamuda S; Zulfah S; Robaha M; Hutahaean J; Anggraeni ND; Kusumaningsih M; Mulyani PS; Sariwati E; Basri HH; Bustos MDG; Syafruddin D Malar J; 2022 Mar; 21(1):95. PubMed ID: 35305658 [TBL] [Abstract][Full Text] [Related]
16. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652 [TBL] [Abstract][Full Text] [Related]
17. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu. Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD Malar J; 2010 Apr; 9():89. PubMed ID: 20370920 [TBL] [Abstract][Full Text] [Related]
18. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria. Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260 [TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia. Hwang J; Alemayehu BH; Hoos D; Melaku Z; Tekleyohannes SG; Teshi T; Birhanu SG; Demeke L; Gobena K; Kassa M; Jima D; Reithinger R; Nettey H; Green M; Malone JL; Kachur SP; Filler S Malar J; 2011 Jul; 10():209. PubMed ID: 21798054 [TBL] [Abstract][Full Text] [Related]
20. [Role of primaquine in malaria control and elimination in French-speaking Africa]. Briolant S; Pradines B; Basco LK Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]